Jack Nathan Medical Corp.
JNH.V
TSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -8.65% | 36.37% | 5.69% | 14.98% | -50.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.65% | 36.37% | 5.69% | 14.98% | -50.89% |
| Cost of Revenue | -0.58% | 30.17% | -18.75% | -7.58% | -60.35% |
| Gross Profit | -10.15% | 38.35% | 13.34% | 23.12% | -48.61% |
| SG&A Expenses | -0.81% | 20.66% | 16.48% | 35.71% | -39.27% |
| Depreciation & Amortization | -46.99% | 18.94% | 50.61% | -11.61% | -71.89% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.19% | 22.68% | 10.63% | 23.19% | -44.73% |
| Operating Income | -18.08% | 183.90% | -37.09% | -60.66% | 8.84% |
| Income Before Tax | -24.94% | 4.14% | 13.04% | -47.18% | 20.16% |
| Income Tax Expenses | 856.55% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -53.27% | -24.79% | 13.04% | -47.18% | 22.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.27% | 615.90% | 13.04% | -47.18% | 22.65% |
| EBIT | -18.08% | 183.90% | -37.09% | -60.66% | 8.84% |
| EBITDA | -85.00% | 95.02% | -29.82% | -92.83% | 18.23% |
| EPS Basic | -51.92% | 610.71% | 14.69% | -43.38% | 24.64% |
| Normalized Basic EPS | -27.27% | 105.00% | -23.68% | -106.78% | 23.26% |
| EPS Diluted | -51.92% | 605.61% | 14.69% | -30.00% | 29.73% |
| Normalized Diluted EPS | -27.27% | 138.46% | -19.44% | -114.04% | 23.26% |
| Average Basic Shares Outstanding | 0.00% | 1.83% | 1.88% | 2.79% | 3.31% |
| Average Diluted Shares Outstanding | 0.00% | 2.22% | 7.39% | -1.08% | 3.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |